This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
n13http://linked.opendata.cz/resource/drugbank/drug/DB07579/identifier/pubchem-compound/
dctermshttp://purl.org/dc/terms/
n4http://linked.opendata.cz/resource/drugbank/drug/DB07579/identifier/pubchem-substance/
n7http://linked.opendata.cz/resource/drugbank/drug/DB07579/identifier/drugbank/
n11http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n10http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n8http://linked.opendata.cz/resource/drugbank/drug/DB07579/identifier/pdb/

Statements

Subject Item
n2:DB07579
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n10:DB07579 n11:DB07579
dcterms:title
BIS-1,2-{[(Z)-2-CARBOXY-2-METHYL-1,3-DIOXANE]-5-YLOXYCARBAMOYL}-ETHANE
adms:identifier
n4:99444050 n7:DB07579 n8:CPJ n13:4369593
n5:IUPAC-Name
n6:271B5206-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B520C-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B520B-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B5208-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B5209-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B520A-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B5204-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B5202-363D-11E5-9242-09173F13E4C5 n6:271B5205-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B5203-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B5212-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B5213-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B520D-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B520E-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B5210-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B520F-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B5211-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B5218-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B521A-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B521B-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B5217-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B5216-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B5219-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B5207-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B5214-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B5215-363D-11E5-9242-09173F13E4C5